G1 Therapeutics Inc. (GTHX)
NASDAQ: GTHX
· Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM
G1 Therapeutics Revenue Breakdown
Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
---|---|---|---|
License Revenue | 36.17M | 19.96M | 20.36M |
License Revenue Growth | +81.16% | -1.93% | n/a |
Product Revenue | 46.34M | 31.34M | 11.12M |
Product Revenue Growth | +47.89% | +181.81% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 13.61M | 15.13M | 15.17M | 16.78M | 17.43M | 21.75M | 23.56M | 24.43M | 25.72M | 26.71M | 23.22M | 24.27M | 25.24M | 22.97M | 24.26M | 18.41M | 14.43M | 11.39M | 12.06M | 11.08M | 9.09M | 7.8M | 7.01M | 4.95M | 3.27M | 3.38M | 2.21M | 1.88M | 1.71M | 1.29M | 1.26M | 918K | 975K | 2.07M |
Selling, General, and Administrative Revenue Growth | -10.03% | -0.26% | -9.62% | -3.73% | -19.86% | -7.66% | -3.58% | -4.99% | -3.72% | +15.04% | -4.33% | -3.84% | +9.87% | -5.32% | +31.76% | +27.59% | +26.73% | -5.59% | +8.82% | +21.87% | +16.57% | +11.30% | +41.62% | +51.44% | -3.26% | +53.13% | +17.65% | +9.52% | +32.29% | +2.65% | +37.32% | -5.85% | -53.01% | n/a |
Research and Development Revenue | 5.74M | 7.32M | 7.38M | 8.81M | 12.04M | 15.48M | 16.59M | 19.58M | 20.84M | 26.3M | 19.79M | 21.14M | 18.75M | 16.54M | 16.37M | 17.93M | 18.53M | 20.43M | 24.49M | 22.94M | 23.49M | 18.08M | 19.08M | 15.87M | 18.39M | 17.35M | 15.07M | 14.05M | 13.67M | 11.08M | 9.14M | 5.7M | 6.45M | 3.87M |
Research and Development Revenue Growth | -21.59% | -0.84% | -16.24% | -26.82% | -22.22% | -6.67% | -15.29% | -6.05% | -20.76% | +32.92% | -6.40% | +12.75% | +13.37% | +1.01% | -8.69% | -3.23% | -9.31% | -16.57% | +6.76% | -2.33% | +29.92% | -5.23% | +20.19% | -13.66% | +5.98% | +15.07% | +7.26% | +2.83% | +23.30% | +21.25% | +60.51% | -11.76% | +66.71% | n/a |